2831. Efficacy and Safety of Gepotidacin for Uncomplicated Urinary Tract Infection: Pooled Subgroup Analyses of the EAGLE-2 and EAGLE-3 Randomized Phase 3 Trials

BACKGROUND: Two large Phase 3 trials showed that gepotidacin, a first-in-class oral triazaacenaphthylene bactericidal antibiotic, was efficacious in treating uncomplicated urinary tract infection (uUTI) in females and had an acceptable safety profile consistent with prior gepotidacin trials. We now...

Descripción completa

Detalles Bibliográficos
Autores principales: Hooton, Thomas M, Perry, Caroline R, Janmohamed, Salim, Sheets, Amanda, Dennison, Jeremy, Millns, Helen, Jarvis, Emily, Huang, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678935/
http://dx.doi.org/10.1093/ofid/ofad500.2441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678935/
http://dx.doi.org/10.1093/ofid/ofad500.2441

Ejemplares similares